Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of MEGF6 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | multiple interactions | ISO | Megf6 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MEGF6 mRNA | CTD | PMID:17942748 | 17beta-estradiol | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of MEGF6 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Megf6 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MEGF6 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MEGF6 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in decreased expression of MEGF6 mRNA | CTD | PMID:29704546 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MEGF6 mRNA | CTD | PMID:29704546 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MEGF6 mRNA | CTD | PMID:17942748 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of MEGF6 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of MEGF6 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | bisphenol S results in decreased methylation of MEGF6 gene | CTD | PMID:31601247 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Megf6 (Mus musculus) | 6480464 | bisphenol S affects the methylation of MEGF6 gene | CTD | PMID:31683443 | 5-azacytidine | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Azacitidine results in decreased expression of MEGF6 mRNA | CTD | PMID:19194470 | 7,12-dimethyltetraphene | decreases expression | EXP | | 6480464 | 9 more ... | CTD | PMID:19480007 | acrylamide | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of MEGF6 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of MEGF6 mRNA | CTD | PMID:22100608 | aflatoxin B1 | affects methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the methylation of MEGF6 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of MEGF6 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | decreases methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of MEGF6 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MEGF6 mRNA | CTD | PMID:23724009 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MEGF6 mRNA | CTD | PMID:16483693 | antirheumatic drug | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of MEGF6 mRNA | CTD | PMID:24449571 | arsane | affects methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | Arsenic affects the methylation of MEGF6 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | Arsenic affects the methylation of MEGF6 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to MEGF6 mRNA] | CTD | PMID:32406909 | arsenous acid | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of MEGF6 mRNA | CTD | PMID:26705709 | arsenous acid | decreases expression | ISO | Megf6 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of MEGF6 mRNA | CTD | PMID:35676786 | benzo[a]pyrene | decreases expression | ISO | Megf6 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MEGF6 mRNA | CTD | PMID:21569818 | benzo[a]pyrene | increases methylation | ISO | Megf6 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of MEGF6 intron | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MEGF6 exon more ... | CTD | PMID:27901495 and PMID:30157460 | benzo[b]fluoranthene | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of MEGF6 mRNA | CTD | PMID:26377693 | benzo[e]pyrene | increases methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of MEGF6 intron | CTD | PMID:30157460 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Megf6 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of MEGF6 mRNA | CTD | PMID:35716406 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MEGF6 mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol A | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MEGF6 mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of MEGF6 gene | CTD | PMID:31601247 | bisphenol F | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of MEGF6 gene | CTD | PMID:31601247 | calcitriol | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of MEGF6 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of MEGF6 mRNA | CTD | PMID:21592394 | carbon nanotube | decreases expression | ISO | Megf6 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chlorpyrifos | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of MEGF6 mRNA | CTD | PMID:37019170 | cisplatin | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MEGF6 mRNA | CTD | PMID:27594783 | cisplatin | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of MEGF6 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of MEGF6 mRNA | CTD | PMID:27392435 | copper(II) sulfate | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of MEGF6 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MEGF6 mRNA | CTD | PMID:25562108 | cyclosporin A | increases methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | Cyclosporine results in increased methylation of MEGF6 promoter | CTD | PMID:27989131 | cyclosporin A | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MEGF6 mRNA | CTD | PMID:27989131 | dexamethasone | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Dexamethasone results in decreased expression of MEGF6 mRNA | CTD | PMID:25047013 | dexamethasone | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of MEGF6 mRNA | CTD | PMID:28628672 | diarsenic trioxide | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of MEGF6 mRNA | CTD | PMID:26705709 | diarsenic trioxide | decreases expression | ISO | Megf6 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of MEGF6 mRNA | CTD | PMID:35676786 | dibenz[a,h]anthracene | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of MEGF6 mRNA | CTD | PMID:36653537 | dorsomorphin | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of MEGF6 mRNA | CTD | PMID:30307764 | fulvestrant | increases methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of MEGF6 gene | CTD | PMID:31601247 | fulvestrant | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of MEGF6 gene and [bisphenol F co-treated with Fulvestrant] results in decreased methylation of MEGF6 gene | CTD | PMID:31601247 | genistein | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | Genistein results in increased expression of MEGF6 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MEGF6 mRNA | CTD | PMID:33387578 | GW 4064 | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | GW 4064 results in increased expression of MEGF6 mRNA | CTD | PMID:26655953 | indometacin | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in decreased expression of MEGF6 mRNA | CTD | PMID:28628672 | methapyrilene | increases methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of MEGF6 intron | CTD | PMID:30157460 | nickel atom | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Nickel results in decreased expression of MEGF6 mRNA | CTD | PMID:24768652 and PMID:25583101 | ozone | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of MEGF6 mRNA | CTD | PMID:35430440 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MEGF6 mRNA | CTD | PMID:33387578 | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of MEGF6 mRNA | CTD | PMID:32680482 | phenylmercury acetate | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of MEGF6 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEGF6 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MEGF6 mRNA | CTD | PMID:19710929 | potassium chromate | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of MEGF6 mRNA | CTD | PMID:22714537 | propanal | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of MEGF6 mRNA | CTD | PMID:26079696 | quercetin | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Quercetin results in increased expression of MEGF6 mRNA | CTD | PMID:21632981 | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of MEGF6 mRNA | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of MEGF6 mRNA | CTD | PMID:25895662 | sodium arsenate | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | sodium arsenate results in increased expression of MEGF6 mRNA | CTD | PMID:30953684 | sodium arsenite | affects methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of MEGF6 gene | CTD | PMID:28589171 | sodium arsenite | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of MEGF6 mRNA | CTD | PMID:34032870 and PMID:35954277 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of MEGF6 mRNA | CTD | PMID:19281266 | sunitinib | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of MEGF6 mRNA | CTD | PMID:31533062 | T-2 toxin | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | T-2 Toxin results in decreased expression of MEGF6 mRNA | CTD | PMID:31863870 | testosterone | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of MEGF6 mRNA | CTD | PMID:21592394 | testosterone | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Testosterone results in increased expression of MEGF6 mRNA | CTD | PMID:21592394 | tetraphene | increases expression | ISO | Megf6 (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of MEGF6 mRNA | CTD | PMID:26377693 | thimerosal | decreases expression | ISO | Megf6 (Mus musculus) | 6480464 | Thimerosal results in decreased expression of MEGF6 mRNA | CTD | PMID:24675092 | titanium dioxide | decreases expression | ISO | Megf6 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of MEGF6 mRNA | CTD | PMID:29264374 | Trapidil | multiple interactions | EXP | | 6480464 | Trapidil affects the reaction [PTH protein affects the expression of MEGF6 mRNA] | CTD | PMID:18635661 | triptonide | affects expression | ISO | Megf6 (Mus musculus) | 6480464 | triptonide affects the expression of MEGF6 mRNA | CTD | PMID:33045310 | tris(2-butoxyethyl) phosphate | affects expression | ISO | MEGF6 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of MEGF6 mRNA | CTD | PMID:29024780 | valproic acid | increases methylation | ISO | MEGF6 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of MEGF6 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MEGF6 mRNA | CTD | PMID:29154799 | valproic acid | increases expression | ISO | MEGF6 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MEGF6 mRNA | CTD | PMID:26272509 and PMID:28001369 | valproic acid | multiple interactions | ISO | MEGF6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MEGF6 mRNA | CTD | PMID:27188386 | |